This is good news for the Quebec Consortium for Drug Discovery (CQDM), which just received $20 million in aid from Quebec for a project aimed at developing a new industrial sector in the field of ribonucleic acid (RNA) therapeutics.
Listen to Diane Gosselin, President and CEO of the Quebec Consortium for Drug Discovery (CQDM), speak with Luc Ferrandez to demystify this rather complex topic!
Related Posts
Lyme Disease and Medical Assistance in Dying: Stephanie Lavoie’s Family Speaks Out
Even though Stephanie Lavoie’s death was carefully planned, it was...
Kwilu now has its own epidemiological intelligence center
The head of the Kwilu Provincial Health Directorate (DPS), Jean-Paul...
Optimizing rabies surveillance in wildlife
In early April, Vermont saw an increase in raccoon rabies...